logo
Product categories

EbookNice.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link.  https://ebooknice.com/page/post?id=faq


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookNice Team

(Ebook) The Role of Biologic Therapy in Inflammatory Bowel Disease, Gastroenterology Clinics of North America Vol 35 Issue 4 by Gary R. Lichtenstein MD ISBN 9781416035558, 1416035559

  • SKU: EBN-1870652
Zoomable Image
$ 32 $ 40 (-20%)

Status:

Available

5.0

14 reviews
Instant download (eBook) The Role of Biologic Therapy in Inflammatory Bowel Disease, Gastroenterology Clinics of North America Vol 35 Issue 4 after payment.
Authors:Gary R. Lichtenstein MD
Pages:196 pages.
Year:2006
Editon:1
Publisher:Saunders
Language:english
File Size:2.38 MB
Format:pdf
ISBNS:9781416035558, 1416035559
Categories: Ebooks

Product desciption

(Ebook) The Role of Biologic Therapy in Inflammatory Bowel Disease, Gastroenterology Clinics of North America Vol 35 Issue 4 by Gary R. Lichtenstein MD ISBN 9781416035558, 1416035559

Dr. Gary Lichtenstein, one of the top experts on IBD, has assimilated an international group of experts who will explore the use of infliximab and other similar biologics for use in patients with Ulcerative Colitis, luminal Crohn's Disease and fistulizing Crohn's disease. The perceived mechanisms of action, and adverse events will be reviewed. Similar agents under investigation will be reviewed. The review will focus on clinically relevant issues for the practicing clinician and also focus on important laboratory based information that the investigator needs to know. Areas of focus include regulatory issues with biologics in IBD, management of infusion reactions in patients receiving infliximab, the economics of use of biologics, recognizing and preventing adverse events with use of infliximab and other biologics, A review of putative targets for novel biologics and also a review of current agents under investigation will also be included. This guide for the experienced researcher and for the novice who has yet to use biologic therapy to treat IBD will be a state of the art overview of the current literature for infliximab and other biologics in IBD. Gastroenterologists, surgeons, family physicians, gynecologists, internists, medical students, nurses and all other health care deliverers who are caring for patients with Inflammatory bowel disease must have this issue because it focuses is on clinically relevant topics, patient management issues; laboratory-based investigations will be touched upon with a translational focus. Key Words: Biologics, Infliximab, monoclonal antibody, Crohn's Disease, Fistulae, Ulcerative Colitis, Refractory Crohn's Disease, novel therapy, economics, fistulae, luminal Crohn's disease, infusion reactions.
*Free conversion of into popular formats such as PDF, DOCX, DOC, AZW, EPUB, and MOBI after payment.

Related Products